The Association Between the Use of Antiarrhythmic Drugs in Non-Valvular Atrial Fibrillation and Patient Prognosis Using Data from the China Atrial Fibrillation (China-AF) Registry

机译：使用中国心房颤动（China-AF）注册中心的数据非瓣膜性房颤使用抗心律失常药物与患者预后之间的关系

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundResults of the landmark Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) trial comparing rhythm control and rate control strategies has led to dramatic changes in the pharmacological management of non-valvular atrial fibrillation (NVAF) patients. We sought to investigate the effect of antiarrhythmic drugs (AADs) on the clinical outcomes of NVAF patients using “real-world” data from China.

机译：背景具有里程碑意义的心律控制心房纤颤随访研究（AFFIRM）试验的结果比较了心律控制和心率控制策略，已导致非瓣膜性心房颤动（NVAF）患者的药理学管理发生了巨大变化。我们试图使用来自中国的“真实世界”数据来研究抗心律失常药物（AAD）对NVAF患者临床结局的影响。

著录项

期刊名称 Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
作者
Xiao-Xia Hou; Xin Du; Danni Zheng; Yan-Ming Li; Liu He; Xin-Xu Li; Jian-Zeng Dong;
展开▼
作者单位

展开▼
年(卷),期 2019(25),-1
年度 2019
页码 4856–4868
总页数 13
原文格式 PDF
正文语种
中图分类
关键词
Anti-Arrhythmia Agents Atrial Fibrillation Prognosis;

机译：抗心律失常药物;房颤;预后;

相似文献

外文文献
中文文献
专利

1. Association between use of amiodarone for non-valvular atrial fibrillation and patient survival:from the prospective China Atrial Fibrillation Registry [J] . Xiao-Xia Hou, Liu He, Xin Du, 中华医学杂志（英文版） . 2021,第003期

机译：非瓣膜心房颤动和患者存活的胺碘酮之间的结合：来自预期中国心房颤动登记
2. Efficacy of antiarrhythmic drug therapy in preventing recurrence of atrial fibrillation and long-term cardiovascular prognosis in patients with asymptomatic paroxysmal atrial fibrillation. [J] . Komatsu T, Tachibana H, Sato Y, International heart journal . 2010,第2期

机译：抗心律失常药物治疗在预防无症状阵发性心房颤动患者中防止房颤复发和长期心血管预后的功效。
3. Efficacy of Antiarrhythmic Drug Therapy in Preventing Recurrence of Atrial Fibrillation and Long-Term Cardiovascular Prognosis in Patients With Asymptomatic Paroxysmal Atrial Fibrillation [J] . Takashi Komatsu, Hideaki Tachibana, Yoshihiro Sato, International heart journal . 2010,第2期

机译：抗心律失常药物疗法预防无症状性阵发性心房纤颤患者房颤复发和长期心血管预后的功效
4. LONG-TERM EFFICACY OF ANTIARRHYTHMIC DRUG THERAPY AND ITS INFLUENCE TO THE PROGNOSIS IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION [C] . KEN OKUMUR International Congress on Electrocardiology . 2005

机译：抗心律失常药物治疗的长期疗效及其对阵发性心房颤动患者预后的影响
5. Cardiac ablation as the initial therapy for symptomatic atrial fibrillation results in less recurrance of atrial fibrillation when compared to antiarrhythmic therapy [D] . Mikhli, Erica 2011

机译：与抗心律失常治疗相比，心脏消融作为症状性心房颤动的初始治疗导致心房颤动的较少复发
6. Long-Term Persistence with Newly-Initiated Warfarin or Non-VKA Oral Anticoagulant (NOAC) in Patients with Non-Valvular Atrial Fibrillation: Insights from the Prospective China-AF Registry [O] . Chang Liu, Xin Du, Chao Jiang, 2019

机译：非瓣膜性心房颤动患者长期服用新开始的华法林或非VKA口服抗凝剂（NOAC）的持久性：前瞻性中国房颤注册中心的见解
7. The Association Between the Use of Antiarrhythmic Drugs in Non-Valvular Atrial Fibrillation and Patient Prognosis Using Data from the China Atrial Fibrillation (China-AF) Registry [O] . Xiao-Xia Hou, Xin Du, Danni Zheng, 2019

机译：使用来自中国心房颤动（China-AF）登记处的数据使用数据使用抗炎药物在非瓣膜心房颤动和患者预后的关联

The Association Between the Use of Antiarrhythmic Drugs in Non-Valvular Atrial Fibrillation and Patient Prognosis Using Data from the China Atrial Fibrillation (China-AF) Registry

摘要

著录项

相似文献

相关主题

期刊订阅